HPV-specific innovations and controversies in therapeutic strategies for HPV-associated oropharyngeal carcinoma
The global surge in human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma (OPSCC) has necessitated a fundamental shift in clinical management. While patients exhibit favorable prognoses compared to HPV-negative counterparts, balan…